Bayer launches $7bn rights issue, finally wraps up Monsanto takeover

Date: 2018-06-04   Author: Saipriya Iyer  Category: #market

Bayer launches $7bn rights issue, finally wraps up Monsanto takeover

Bayer AG, a pharma giant headquartered in Germany, has introduced rights offering that is estimated at USD 7 billion. Through this strategic move, the company reportedly aims to close its USD 62.5 billion acquisition of Monsanto, an agrochemical & agricultural biotech firm. Incidentally, last week, Bayer secured the nod of approval from the U.S. for the acquisition deal, clearing its last antitrust hurdle for approval in the country.

As per the official statement, Bayer will now remain the sole company name, while Monsanto will lose its brand value. The acquired product portfolio will now become a part of Bayer product and service range, the statement claims.

For the record, the regulatory approval for Bayer’s takeover of Monsanto has come with quite a price. The company had reportedly agreed to divest its seed and pesticide assets worth EUR 7.6 billion euros to gain the approval of the European and U.S. antitrust regulators. Additionally, the company raised EUR 4.5 billion more than initially planned from the sale of its stake in Covestro.

Bayer’s chief executive Werner Baumann has been quoted stating that the company basically aims to connect better with the society, heeding to critics’ advice and working together to find a common ground without conflicts. He further said that the field of agriculture is far too important to be disrupted by ideological differences that may hamper progress.

For the uninitiated, the acquisition is the first of the three pivotal U.S.-German merger deals that has reached closure amidst a scenario plagued by President Donald Trump’s harsh criticism of Germany's trade surplus with the U.S.

As per official sources, the acquisition deal is now expected to be wrapped up any day now. A source familiar with the latest developments announced that the deal would be finalized on the 7th of this month.



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Endovascular Aneurysm Repair (Evar) Stent Grafts Market Report Till 2025 | Industry Analysis & Forecast

Author: Sachin Pashte

Global Endovascular Aneurysm Repair (Evar) Stent Grafts Market 2020 Includes Market Size, Share, Trends, Growth, Demand, Supply, Application, Segmentation, Opportunity, Market Development, Production, Capacity Utilization, Supply, Analysis and For...


Air Cargo Screening System Market Size, Share, Statistics, Demand and Revenue, Forecast 2025

Author: Sachin Pashte

The latest trending report Global Air Cargo Screening System Market to 2025 available at MarketStudyReport.com is an informative study covering the market with detailed analysis. The report will assist reader with better understanding and decision...


Imipenem and Cilastatin Sodium Market: Business Opportunities, Current Trends and Industry Analysis by 2020 - 2025

Author: Sachin Pashte

This report studies the Global Imipenem and Cilastatin Sodium market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major region...